Skip to content

Predictive Monitoring - IMPact in Acute Care Cardiology Trial

Predictive Monitoring - IMPact in Acute Care Cardiology Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04359641
Acronym
PM-IMPACCT
Enrollment
10424
Registered
2020-04-24
Start date
2021-01-04
Completion date
2028-03-31
Last updated
2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Deterioration

Brief summary

Hypothesis: display of predictive analytics monitoring on acute care cardiology wards improves patient outcomes and is cost-effective to the health system. The investigators have developed and validated computational models for predicting key outcomes in adults, and a useful display has been developed, implemented and iteratively optimized. These models estimate risk of imminent patient deterioration using trends in vital signs, labs and cardiorespiratory dynamics derived from readily available continuous bedside monitoring. They are presented on LCD monitors using software called CoMET (Continuous Monitoring of Event Trajectories; AMP3D, Advanced Medical Predictive Devices, Diagnostics, and Displays, Charlottesville, VA) To test the impact on patient outcomes, the investigators propose a 22-month cluster-randomized control trial on the 4th floor of UVa Hospital, a medical-surgical floor for cardiology and cardiovascular surgery patients. Clinicians will receive standard CoMET device training. Three- to five-bed clusters will be randomized to intervention (predictive display plus standard monitoring) or control (standard monitoring alone) for two months at a time. In addition, risk scores for patients in the intervention clusters will be presented daily during rounds to members of the care team of physicians, residents, nurses, and other clinicians. Data on outcomes will be statistically compared between intervention and control clusters.

Interventions

DEVICECoMET Display

Display and presentation of predictive monitoring score CoMET

Sponsors

Advanced Medical Predictive Devices, Diagnostics and Displays, Inc.
CollaboratorUNKNOWN
Jamieson Bourque, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Assigned for clinical purposes to a beds which is part of a randomized cluster

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Hours free of events of clinical deteriorationwithin 21 days of the admission(1) The number of hours free of acute clinical events within 21 day of admission. Hours of acute clinical events are defined as time when one or more of the following occur: * An emergent ICU transfer (emergent defined as urgent, unplanned) and ICU stay * Emergent intubation (emergent is defined by clinician's notes as a non-planned procedure) * Cardiac arrest, if prior to ICU transfer or death * Death A maximum score will be 21 event-free days (504 hours). Patients who are discharged from the hospital prior to 21 days without an event will be counted as having 21 event-free days. Patients who die during the admission will be counted as having 0 event-free days. Patients will be censored (with no event observed) at the time of non-emergent ICU transfer, surgery transfer, or other transfer.

Secondary

MeasureTime frameDescription
Subgroup secondary outcome: post-ICU transfer event-free survivalthrough study completion, on average one weekA subgroup secondary outcome will be a Kaplan Meier or Cox Proportional Hazard curve showing post-ICU transfer, event-free survival, hours free of the following events: * Time of emergent intubation post-ICU transfer (emergent is defined by clinician's notes as a non-planned procedure) * Time of the 1st order post-ICU transfer for transfusion of 3 units or more of blood ordered within 24 hours * Time of first order post-ICU transfer of IV inotropes or pressors * Time of cardiac arrest post-ICU transfer * Time of CHF escalation, defined by the time of first order for diuretic drip, time of first order for CVVHD, or time of dialysis initiation * Time of death post-ICU transfer * Discharge from the ICU without an event will count as infinite event-free survival.
Proportion of Emergent ICU transfer at any point in the hospital staythrough study completion, on average one weekProportion of patients experiencing emergent ICU transfer (emergent defined as urgent, unplanned) at any point in the hospital stay after admission to the fourth floor:
Proportion of emergent intubation at any point in the hospital staythrough study completion, on average one weekProportion of patients experiencing emergent intubation (emergent is defined by clinician's notes as a non-planned procedure) at any point in the hospital stay after admission to the fourth floor
Proportion of 3 units or more of blood ordered in 24 hours at any point in the hospital staythrough study completion, on average one weekProportion of patients with 3 units or more of blood ordered in 24 hours at any point in the hospital stay after admission to the fourth floor
Proportion of IV inotropes or pressors at any point in the hospital staythrough study completion, on average one weekProportion of patients receiving IV inotropes or pressors at any point in the hospital stay after admission to the fourth floor
Proportions of Shock requiring inotropes or pressors at any point in the hospital staythrough study completion, on average one weekProportions of patients with shock requiring inotropes or pressors at any point in the hospital stay after admission to the fourth floor
Proportion of Sepsis 2 criteria at any point in the hospital staythrough study completion, on average one weekProportion of patients meeting Sepsis 2 criteria at any point in the hospital stay after admission to the fourth floor
Proportion of septic shock at any point in the hospital staythrough study completion, on average one weekProportion of patients with septic shock requiring inotropes or pressors (defined by a combination of Outcome 8 and 9) at any point in the hospital stay after admission to the fourth floor
Proportion of Cardiac arrest at any point in the hospital staythrough study completion, on average one weekProportion of patients experiencing cardiac arrest at any point in the hospital stay after admission to the fourth floor
Proportion of death at any point in the hospital staythrough study completion, on average one weekProportion of patients experiencing death at any point in the hospital stay after admission to the fourth floor
Hours to proactive clinical responsethrough study completion, on average one weekWe will use a Kaplan Meier or Cox Proportional Hazard Curve to determine differences in response time between display and control. * Time to the 1st order for transfusion of 3 units or more of blood ordered within 24 hours * Time to first order for IV inotropes or pressors administered * Time to first order for blood or urine culture obtained for suspicion of infection * Time to first order for lactate drawn * Time to first order for antibiotics given for suspicion of infection * Time to first order for fluid resuscitation given for suspicion of shock * Time to rapid response team (RRT or MET) call initiation.
Proportion of Inotropes or pressors for refractory heart failure at any point in the hospitalthrough study completion, on average one weekProportion patients receiving inotropes or pressors for refractory heart failure at any point in the hospital stay after admission to the fourth floor
Hospital length of staythrough study completion, on average one weekHospital length of stay
Length of stay on floorthrough study completion, on average one weekIn patients who are never transferred to the ICU, the length of stay on the floor.
ICU length of staythrough study completion, on average one weekICU length of stay
Hospital readmissionwithin 72 hours post-dischargeReadmission to hospital within 72 hours post-discharge
Shock in sepsisthrough study completion, on average one weekIn patients who meet the Sepsis 2 criteria, the proportion of Shock, i.e. Hypotension requiring inotropes or pressors
Death in sepsisthrough study completion, on average one weekIn patients who meet the Sepsis 2 criteria, the proportion of death
Cost of Carethrough study completion, on average one weekObserved:Expected ratio
Number of days on IV antibioticsthrough study completion, on average one weekNumber of days on IV antibiotics
duration of mechanical intubationthrough study completion, on average one weekTotal duration of mechanical intubation (emergent and non-emergent)
Proportion of Congestive heart failure at any point in the hospital staythrough study completion, on average one weekProportion of patients receiving diuretic drip indicating Congestive Heart Failure escalation at any point in the hospital stay after admission to the fourth floor

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026